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ABSTRACT
Streptococcus vestibularis is a recently described member of the viridans group that was fi rst isolated 
from the vestibular mucosa of the human oral cavity and described as a new species in 1988. It has 
been rarely associated with human infections. In few papers, it has been reported as a causal agent 
of systemic infection in immunosupressed adults and in those with other severe underlying diseases, 
like coronary valve diseases. A 65-year-old woman was admitted to the hospital with complaints of 
fever for three months, general malaise, effort dyspnea, weight loss, back pain and myalgia. Both 
native aortic valve endocarditis and spondylodiscitis due to Streptococcus vestibularis were detected. 
The patient was successfully treated with intravenous potassium penicillin G and gentamicin for six 
weeks, followed by oral amoxicillin for three months, in addition to aortic valve replacement. In all 
patients with spondylodiscitis, infective endocarditis should be considered, particularly in patients 
with heart valve disease history, since spondylodiscitis may be the presenting sign of an infective en-
docarditis. Cardiac valve replacement surgery should be performed if the course of fever and inﬂ am-
matory syndrome is unfavorable after appropriate antibiotic treatment. We report the fi rst case with 
both native aortic valve endocarditis and spondylodiscitis due to Streptococcus vestibularis.
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INTRODUCTION
Streptococcus vestibularis is a member of the sal-
ivarious group of viridans streptococci. Many 
of the viridans streptococcal species are part of 
human normal microbial ﬂ ora. The commen-
sal species are most prevalent in the oral cav-
ity. S. vestibularis has been accepted as an im-
portant nosocomial pathogen and an atypical 
cause of signifi cant septicemia in the presence 
of mucosal lesions, immune compromising 
states, malignancy, liver cirrhosis, renal failure 
or chronic diseases, such as diabetes mellitus. S. 
vestibularis has been reported to be associated 
with severe human infections, such as menin-
gitis, endocarditis, bacteremia, and bone and 
joint infections.1-4 Infective endocarditis (IE) 
occurs in older age group (over the age of 60) 
who has prosthetic valves or structural heart 
diseases. Few of them have underlying rheu-
matic valve disease or intravenous drug abuse. 
Staphylococcus aureus and viridans streptococci 
are the most common causes of native valve 
infective endocarditis. Usually, more than 50% 
of all cases of IE are caused by viridans strep-
tococci. Many members of the viridans fam-
ily are known to be able to cause IE, includ-
ing Streptococcus mitis, Streptococcus sanguis, 
Streptococcus mutans, Streptococcus salivarus 
and Streptococcus oralis. New etiological agents 
have been recently described.5,6 Other mem-
bers of the viridans group are also able to cause 
IE, but poorly defi ned taxonomy and diffi cul-
ties in specifi cation prevent this ascertainment 
from being made. Few cases of prosthetic valve 
IE due to S. vestibularis were reported.7 The 
only case of native valve endocarditis due to 
S. vestibularis was reported as a coinfection with 
S. oralis.6 In the literature, there is no case re-
port about native valve endocarditis caused by 
S. vestibularis as a single causative pathogen. Less 
than 4% of patients with endocarditis actually 
demonstrate spondylodiscitis.8 Spondylodisci-
tis is a prolonged inﬂ ammation of two adjacent 
vertebral bodies and the disc between them. 
Due to the avascular nature of the interver-
tebral disc space in adults, spondylodiscitis is 
rarely observed. Eighty percent of spondylo-
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discitis were hematogenous, and 20% developed after spinal 
surgery.8 Potential sources of hematogenous or contiguous 
spread of infection include the genitourinary tract, skin and 
soft tissue, respiratory tract, infected intravenous catheters, 
postoperative wound infections, endocarditis, and dental 
infections. However, the primary site of infections cannot 
be identifi ed in most of cases. Less common causes include 
infected native or prosthetic valves.9 Staphylococcus aureus 
is the most frequent cause of spondylodiscitis, followed by 
Streptococcus spp, Escherichia coli and Mycobacterium tuber-
culosis.10 Until this report, there has been no previous report 
of spondylodiscitis and native valve endocarditis due to S. 
vestibularis in the literature.
 
CASE REPORT
A 65-year-old woman was admitted to the hospital with 
complaints of fever for three months, general malaise, effort 
dyspnea, weight loss, back pain and myalgia. From her medi-
cal history it was learned that she had hypertension for three 
years. She was on atenolol 50 mg daily. She had suddenly 
started to feel back pain three months previously, without 
trauma or brisk movement. The pain worsened with move-
ment and she was admitted to another hospital with these 
complaints. Her laboratory tests were unremarkable, except 
for elevated C-reactive protein (CRP) (77 mg/L) and eryth-
rocyte sedimentation rate (ESR) (37 mm/h). Chest radiogra-
phy revealed elevated density on the bilateral inferior zones. 
Chest computed tomography showed mild septal lines and 
pleural thickening. Atypical pneumonia was considered and 
the patient was put on 400 mg of moxiﬂ oxacin intravenous-
ly, daily, for two weeks. After cessation of antibiotic therapy, 
there was a mild decrease of acute phase proteins and she 
was subsequently discharged. One month later, she was ad-
mitted to our hospital with low back pain, fever, high CRP 
(220 mg/L) and ESR (90 mm/h) levels. Palpation and per-
cussion of the 6-7th thoracic vertebrae revealed tenderness. 
The neurological examination was normal. Complete blood 
count and biochemical analyses were within normal limits. 
During the fi rst few days of hospitalization, she had fever 
(39 oC) and a 2/6 pansystholic murmur on physical exami-
nation. Blood cultures were taken. The plain radiography of 
thoracic vertebra was normal. Magnetic resonance imaging 
(MRI) showed pathological enhancement on intervertebral 
disc space and neighboring endplates, considering spondy-
lodiscitis at 6-7th thoracic intervertebral disc space (Figure 1). 
Bone scintigraphy demonstrated high activity in T7 verte-
bra body. Serum brucella agglutination test was negative and 
tuberculin skin test was found to be negative (induration 
< 5 mm). The electrocardiogram revealed sinus tachycar-
dia. Transthoracic and transesophageal echocardiography 
revealed two calcifi c mobile vegetations (1.1 x 0.7 cm, 1.6 x 
0.8 cm) on the aortic valve, compatible with endocarditis. A 
computed tomography guided needle biopsy of the interver-
tebral space at T6-7 was performed. S. vestibularis was grown 
both in blood cultures taken on the fi rst hospitalization day 
and in the culture of fi ne needle aspiration specimen of in-
tervertebral space. Bone marrow cultures were also positive 
for the same agent. The patient received 6 x 4 million units 
of potassium penicillin G daily intravenously and 240 mg/
daily gentamicin intravenously for six weeks. Although fever 
resolved, high CRP level, effort dyspnea and tachycardia per-
sisted. Since the endocardial lesions showed progression, she 
underwent aortic valve replacement. The patient recovered 
after operation and was discharged from hospital. Three 
grams of oral amoxicillin daily was administrated for three 
months. Control MRI showed no evidence of inﬂ ammation 
on T6-7 intervertebral space. Blood cultures were negative. 
Three years follow up was uneventful.
 
DISCUSSION
Oral streptococci are among the most common causes of 
infective endocarditis. S. vestibularis is a newly described 
species within the viridans streptococci group.11 S. vestibu-
laris is an extremely rare cause of bacteremia and endocar-
ditis, especially in older persons or in patients who have 
underlying chronic disease. In our case, except for being 
elderly, there were no risk factors, such as diabetes mellitus, 
malignancy, use of immunosuppressant, operation and/or 
rheumatoid arthritis. 
Spondylodiscitis is rarely observed in association with 
infective endocarditis. Le Moal et al.12 reported that the prev-
alence of spondylodiscitis in patients with IE was of 15%. 
Spondylodiscitis, however, has rarely been described, partic-
Figure 1: Sagittal precontrast (a) and postcontrast (b) 
T1 weighted MR images show enhancement of the T6-7 
intervertebral disc space and adjacent vertebrae endplates.
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ularly in case reports. Ninet et al.13 found the prevalence of 
spondylodiscitis in patients with IE to be of 5.9%, whereas 
Thomas et al.14 reported a prevalence of 3.7%. Spondylodis-
citis does not appear to worsen the prognosis of IE, although 
the need for cardiac valve replacement seems to be more fre-
quent in IE patients with spondylodiscitis. Presenting symp-
toms are variable and sometimes may delay the diagnosis. 
The mean duration of symptoms from onset to diagnosis 
ranges from two days to six months. A careful review of 
the patient’s history and fi ndings of physical examination, 
as well as laboratory data and diagnostic imaging studies 
are necessary. Musculoskeletal symptoms can represent the 
major sign of the disease, leading to diagnostic diffi culties.12 
Musculoskeletal symptoms are common complaints, espe-
cially in the aging population. These similar symptoms also 
occur in up to 45% of patients with IE and are often misdiag-
nosed as rheumatic or degenerative joint disease. Arthralgia 
is the most common musculoskeletal complaint in patients 
with IE and involves shoulder most frequently, followed by 
knee, hip, wrist, ankle, and the joints of the hands and feet. 
Back pain is second in frequency, affecting almost a third of 
patients with IE. Usually, the patient presents with decreased 
range of motion and spinal tenderness.12 As regards the 
pathogenesis, some authors have suggested that back pain is 
due to microemboli of immune complexes with or without 
bacteria.15 The lumbar region is most commonly involved 
(60%), and thoracic spine can also be affected (26%). Neu-
rologic defi cits are usually not demonstrable in patients with 
back pain.16 Radiographic studies and bone scans confi rm 
disease at the site, which may be caused by septic emboli. 
Common to all patients with IE, fever and heart murmur 
can be detected on physical examination and Gram-positive 
cocci can be isolated from blood cultures.
Naturally, the fi rst choice must be the antibiotictherapy, 
both for IE and spondylodiscitis treatment. Cardiac valve 
replacement surgery should be performed if the course of 
fever and inﬂ ammatory syndrome is unfavorable after ap-
propriate antibiotic treatment.
 
CONCLUSION
We conclude that, in all patients with spondylodiscitis, infec-
tive endocarditis should be ruled out, particularly in patients 
with a history of heart valve disease, since spondylodiscitis 
may be the presenting sign of an infective endocarditis. 
Echocardiography and blood cultures should be routinely 
performed in these patients. Cardiac valve replacement sur-
gery should be performed if the course of fever and inﬂ am-
matory syndrome is unfavorable after appropriate antibiotic 
treatment. We present a unique case of concomitant native 
valve endocarditis and spondylodiscitis caused by S. vestibu-
laris. As the taxonomy of the viridans group becomes bet-
ter defi ned, it is likely that novel disease associations will be 
made with the newly recognized species.
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